Draper is an independent, not-for-profit corporation, which means its primary commitment is to the success of clients’ missions rather than to shareholders. For either government or private sector customers, Draper leverages its deep experience and innovative thinking to be an effective engineering research and development partner, designing solutions or objectively evaluating the ideas or products of others. Draper will partner with other organizations…
Our mission is to accelerate the discovery of new medicines with physiologically-relevant, structured human cells in high density plates. We develop and manufacture human induced pluripotent stem cell-derived cardiac and neuronal platforms for high throughput drug toxicity and efficacy screening. Predictive, accurate, and consistent, our human models enable scientists to economically conduct research in a simplified workflow…
SynVivo offers 3D cell-based models that enable real-time study of cell and drug interactions and accelerates discovery by providing a biologically realistic platform that more accurately depicts in vivo reality. Complex in vivo microvascular environment including scale, morphology, hemodynamics and cellular architecture are re-created in an in vitro format. SynVivo’s 3D models for blood brain barrier, tumor, inflammation and toxicology are morphologically and physiologically realistic and feature a side-by-side architecture enabling real-time visualization using standard analytical instrumentation. www.synvivobio.com
Epistem provided specialist preclinical and discovery solutions for drug development. The company applies its knowledge of epithelial tissue and adult stem cells to the area of epithelial repair, oncology, mucositis, inflammation and dermatology and has innovative platforms for both biomarkers development and molecular diagnostics.
TARA Biosystems, Inc. provides predictive, in vitro human cardiac tissue models for use in drug discovery and safety assessment. TARA Biosystems offers a high fidelity solution that is based on human stem cell-derived cardiac tissue matured to physiologically relevant adult-like levels and provides direct measures of cardiac functionality, including contractile force. The TARA solution will provide safety data earlier in the development cycle and a high fidelity discovery model.
AxoSim’s Nerve-on-a-Chip technology predicts clinical results from the benchtop, helping pharmaceutical companies develop safer and more effective drugs. Employing micro-engineering techniques and novel biomaterials, AxoSim has developed a 3D iPSC-based model which mimics living tissue in both form and function, enabling in vivo metrics from an in vitro platform. The Nerve-on-a-Chip platform delivers high-content data as a more accurate, less expensive, and faster alternative to animal testing.
East River BioSolutions is pioneering novel tissue-specific extracellular matrix (ECM) biomaterials to meet research needs in stem cell and cancer research, drug testing, tissue engineering, and regenerative medicine. East River Bio’s TissueSpec™ ECM products are commercially available in the form of matrix hydrogels, and scaffolds for 3D cell culture applications and media supplements, and surface coatings for 2D cell culture applications. Standard and custom-order TissueSpec™ Matrix Kits are available for in vitro life sciences research.